MMJ Group Holdings Limited (ASX: MMJ) ("MMJ") is pleased to attach a copy of a news release by MediPharm Labs Inc (“MediPharm Labs”) (TSX-V: LABS) (OTCQB: MLCPF) announcing that it had purchased over 1,600 kg of additional dried cannabis from 7 different licensed producers between December 18, 2018 and January 8, 2019, replenishing and increasing inventory to ensure uninterrupted cannabis oil supply for its existing customers for Q1 2019 and to satisfy the robust and growing market demand for high quality purified concentrates.
MMJ owns approximately 4.4 million shares for a 4.3% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
For more information, download the attached PDF.
Download this document
